Related Experiment Video
Updated: May 29, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
An Unusual Case of Psoriasiform Dermatitis Treated With Dual Biologic Therapy and Literature Review
Abstract:
Previously believed to be of distinct immunopathogenesis, atopic dermatitis (AD) and psoriasis (PsO) spectrum may permit immunologic shifts to favor the opposing inflammatory states following biologic treatment. Cases of AD that developed following PsO biologics are increasingly reported in the literature. While biologic monotherapy is becoming more widely available, dual biologic therapies have been understudied. Here, we present a patient with biopsy-confirmed PsO who developed psoriasiform spongiotic dermatitis following anti-IL-17A initiation who responded to combination anti-IL-23 and anti-IL-4Ra therapy and discussed the PsO-AD immunologic spectrum and use of dual biologic therapies. J Drugs Dermatol. 2025;24(2):207-211. doi:10.36849/JDD.8382R1.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

